Literature DB >> 10539812

Variations in family physicians' and cardiologists' care for patients with heart failure.

D W Baker1, R P Hayes, B M Massie, C A Craig.   

Abstract

BACKGROUND: Improved understanding of the reasons for underuse of diagnostic tests and treatments for congestive heart failure (CHF) may be helpful for designing future interventions to improve quality of care.
METHODS: To determine differences between family physicians' and cardiologists' practice styles for diagnosis and treatment of CHF, a random sample of family physicians and cardiologists were surveyed with standardized case scenarios.
RESULTS: Survey respondents were 182 family physicians and 163 cardiologists. Family physicians were less likely than cardiologists to rate measurement of left ventricular ejection fraction as "very important" for patients with new CHF, less likely to order an echocardiogram or test for ischemia, and much less likely to identify diastolic dysfunction as a cause of CHF. Family physicians were more likely to prescribe digoxin when it was not indicated (diastolic dysfunction) and less likely to prescribe digoxin and an angiotensin-converting enzyme (ACE) inhibitor when they were indicated (moderately to severely reduced left ventricular ejection fraction). Family physicians expressed more concern over the risks of ACE inhibitors in patients with blood pressure of 100/70 mm Hg or serum creatinine of 2.0 mg/dL and were less likely to prescribe an ACE inhibitor in these settings. Family physicians overestimated the risks of warfarin use for atrial fibrillation and were therefore less likely to prescribe warfarin.
CONCLUSIONS: Family physicians appear to have less understanding of CHF pathophysiology (ie, systolic versus diastolic dysfunction) and how treatment differs according to the underlying disease process. Overestimation of the risk of ACE inhibitor and warfarin use may result in underprescribing these medications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10539812     DOI: 10.1016/s0002-8703(99)70006-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

1.  Management of congestive heart failure: how well are we doing?

Authors:  N Giannetti
Journal:  CMAJ       Date:  2001-08-07       Impact factor: 8.262

2.  Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry.

Authors:  Yevgeniy Khariton; Adrian F Hernandez; Gregg C Fonarow; Puza P Sharma; Carol I Duffy; Laine Thomas; Xiaojuan Mi; Nancy M Albert; Javed Butler; Kevin McCague; Michael E Nassif; Fredonia B Williams; Adam DeVore; J Herbert Patterson; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-04

Review 3.  Strategies to reduce length of stay and costs associated with decompensated heart failure.

Authors:  J Thomas Heywood; Mitchell T Saltzberg
Journal:  Curr Heart Fail Rep       Date:  2005-09

4.  Using spatial analysis to demonstrate the heterogeneity of the cardiovascular drug-prescribing pattern in Taiwan.

Authors:  Ching-Lan Cheng; Yi-Chi Chen; Tzu-Ming Liu; Yea-Huei Kao Yang
Journal:  BMC Public Health       Date:  2011-05-24       Impact factor: 3.295

5.  Changes in under-treatment after comprehensive geriatric assessment: an observational study.

Authors:  Linda R Tulner; Jos P C M van Campen; Suzanne V Frankfort; Cornelis H W Koks; Jos H Beijnen; Desiderius P M Brandjes; Paul A F Jansen
Journal:  Drugs Aging       Date:  2010-10-01       Impact factor: 3.923

Review 6.  Treating the right patient at the right time: access to specialist consultation and non-invasive testing.

Authors:  Merril L Knudtson; Rob Beanlands; James M Brophy; Lyall Higginson; Brad Munt; John Rottger
Journal:  Can J Cardiol       Date:  2006-08       Impact factor: 5.223

7.  Comparison of a spatial approach with the multilevel approach for investigating place effects on health: the example of healthcare utilisation in France.

Authors:  Basile Chaix; Juan Merlo; Pierre Chauvin
Journal:  J Epidemiol Community Health       Date:  2005-06       Impact factor: 3.710

8.  Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study.

Authors:  Dominique Deplanque; Didier Leys; Lucilla Parnetti; Reinhold Schmidt; Jose Ferro; Jacques De Reuck; Jean-Louis Mas; Virgilio Gallai
Journal:  Br J Clin Pharmacol       Date:  2004-06       Impact factor: 4.335

Review 9.  Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study.

Authors:  Linda R Tulner; Jos P C M Van Campen; Ingeborg M J A Kuper; George J P T Gijsen; Cornelis H W Koks; Melvin R Mac Gillavry; Harm van Tinteren; Jos H Beijnen; Desiderius P M Brandjes
Journal:  Drugs Aging       Date:  2010-01-01       Impact factor: 3.923

10.  Changes in heart failure medications in patients hospitalised and discharged.

Authors:  Martin Scherer; Cordula Sobek; Dirk Wetzel; Janka Koschack; Michael M Kochen
Journal:  BMC Fam Pract       Date:  2006-11-23       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.